Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceutcl
(NQ:
LXRX
)
1.990
-0.100 (-4.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lexicon Pharmaceutcl
Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027
October 25, 2023
EQNX::TICKER_START (OTCPK:CNER),(NYSE:NVO),(NASDAQ:TNDM),(NASDAQ:DXCM),(NASDAQ:LXRX) EQNX::TICKER_END
Via
FinancialNewsMedia
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Investor Notice: Investigation over Potential Wrongdoing
May 09, 2022
San Diego, CA -- (SBWIRE) -- 05/09/2022 -- Certain directors of Lexicon Pharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Investor Notice: Investigation over Potential Securities Laws Violations
March 24, 2022
San Diego, CA -- (SBWIRE) -- 03/24/2022 -- An investigation was announced over possible violations of securities laws by Lexicon Pharmaceuticals, Inc.
Via
SBWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.